Literature DB >> 17105404

Syngenic bone marrow cells restore hepatic function in carbon tetrachloride-induced mouse liver injury.

Yun-Jae Jung1, Kyung-Ha Ryu, Su Jin Cho, So-Youn Woo, Ju-Young Seoh, Chung Hyun Chun, Kwon Yoo, Il-Hwan Moon, Ho-Seong Han.   

Abstract

Progenitor cells in bone marrow have been explored for the treatment of liver injury. Stem cell homing to the injured tissue is regulated through stromal cell derived factor-1 (SDF-1) and its receptor CXCR4. We hypothesized that syngenic bone marrow cells (BMCs) would restore hepatic function in the injured liver through the regulation by SDF-1/CXCR4 system. After injecting carbon tetrachloride (CCl(4)), the mice were injected with syngenic BMCs or normal saline. Morphological and functional analysis of the liver was performed. Flow cytometry for the stem cell markers and CXCR4 was done with the liver, BM, and spleen cells from each group. Carboxyfluorescein diacetate succinimidyl ester was used to trace the homing of transplanted BMCs. The SDF-1 expression of the liver was assessed by immunohistochemistry. Hepatosplenomegaly and necrosis of the CCl(4)-injected mouse liver were improved after BMCs transplantation The hepatic enzymes were increased after injury and then decreased after BMCs transplantation. The expression of stem cell markers and CXCR4 was exclusively increased in the damaged liver compared to the BM and spleen, and even more elevated after BMCs transplantation. SDF-1 expression in the liver was observed after CCl(4) injection and it was elevated after BMCs transplantation. The intrinsic and extrinsic BMCs migrate specifically to the injured liver rather than BM or spleen, and the transplanted BMCs contribute to the repair of the damaged liver. SDF-1/CXCR-4 interaction plays a role in stem cell homing toward the damaged organ, and transplanted BMCs are involved in the up-regulated SDF-1 expression seen in the injured liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105404     DOI: 10.1089/scd.2006.15.687

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  4 in total

1.  Liver stem cells derived from the bone marrow and umbilical cord blood.

Authors:  Kyung Ha Ryu
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

2.  Role of Bone Marrow Mesenchymal Stem Cells in the Treatment of CCL4 Induced Liver Fibrosis in Albino Rats: A Histological and Immunohistochemical Study.

Authors:  Soheir Kamal Ahmed; Somaya A Mohammed; Gehan Khalaf; Heba Fikry
Journal:  Int J Stem Cells       Date:  2014-11       Impact factor: 2.500

3.  Identification of miR-27b as a novel signature from the mRNA profiles of adipose-derived mesenchymal stem cells involved in the tolerogenic response.

Authors:  Kuang-Den Chen; Shigeru Goto; Li-Wen Hsu; Tzu-Yang Lin; Toshiaki Nakano; Chia-Yun Lai; Yen-Chen Chang; Wei-Teng Weng; Yur-Ren Kuo; Chih-Chi Wang; Yu-Fan Cheng; Yen-Ying Ma; Chih-Che Lin; Chao-Long Chen
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

4.  Embryonic stem cells reduce liver fibrosis in CCl4-treated mice.

Authors:  Kei Moriya; Masahide Yoshikawa; Yukiteru Ouji; Ko Saito; Mariko Nishiofuku; Ryosuke Matsuda; Shigeaki Ishizaka; Hiroshi Fukui
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.